US 12145941
Heterocyclic antiviral agents
granted A61PA61P31/14
Quick answer
US patent 12145941 (Heterocyclic antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P31/14